Interactive effect of increased high sensitive C-reactive protein and dyslipidemia on cardiovascular diseases: a 12-year prospective cohort study.

BACKGROUND: Dyslipidemia and inflammation are significant factors for the onset of cardiovascular diseases (CVD); however, studies regarding their interactions on the risk of CVD are scarce. This study aimed to assess the interaction of dyslipidemia and high-sensitivity C-reactive protein (hs-CRP) on CVD. METHODS: This prospective cohort enrolled 4,128 adults at baseline in 2009 and followed them up until May 2022 for collecting CVD events. Cox-proportional hazard regression analysis estimated the hazard ratios (HRs) and 95% confidence intervals (CIs) of the associations of increased hs-CRP (≥ 1 mg/L) and dyslipidemia with CVD. The additive interactions were explored using the relative excess risk of interaction (RERI) and the multiplicative interactions were assessed with HRs (95% CI) while the multiplicative interactions were assessed by the HRs (95% CI) of interaction terms. RESULTS: The HRs of the association between increased hs-CRP and CVD were 1.42 (95% CI: 1.14-1.79) and 1.17 (95% CI: 0.89-1.53) among subjects with normal lipid levels and subjects with dyslipidemia, respectively. Stratified analyses by hs-CRP levels showed that among participants with normal hs-CRP (< 1 mg/L), TC ≥ 240 mg/dL, LDL-C ≥ 160 mg/dL, non-HDL-C ≥ 190 mg/dL, ApoB < 0.7 g/L, and LDL/HDL-C ≥ 2.02 were associated with CVD [HRs (95%CIs): 1.75 (1.21-2.54), 2.16 (1.37-3.41), 1.95 (1.29-2.97), 1.37 (1.01-1.67), and 1.30 (1.00-1.69), all P < 0.05, respectively]. While in the population with increased hs-CRP, only ApoAI > 2.10 g/L had a significant association with CVD [HR (95% CI): 1.69 (1.14-2.51)]. Interaction analyses showed that increased hs-CRP had multiplicative and additive interactions with LDL-C ≥ 160 mg/dL and non-HDL-C ≥ 190 mg/dL on the risk of CVD [HRs (95%CIs): 0.309 (0.153-0.621), and 0.505 (0.295-0.866); RERIs (95%CIs): -1.704 (-3.430-0.021 and - 0.694 (-1.476-0.089), respectively, all P < 0.05]. CONCLUSION: Overall our findings indicate negative interactions between abnormal blood lipid levels and hs-CRP on the risk of CVD. Further large-scale cohort studies with trajectories measurement of lipids and hs-CRP might verify our results as well explore the biological mechanism behind that interaction.

Sex and age differences in the association between high sensitivity C-reactive protein and all-cause mortality: A 12-year prospective cohort study.

To explore the influence of age on hs-CRP among men and women and investigate the impact of hs-CRP on all-cause death, this prospective cohort enrolled 4128 community adults from 2009 to 2022 for all-cause death. Age and sex-specific hs-CRP percentile curves were generated using the GAMLSS method. Cox-proportional hazard regression analysis was applied to estimate the hazard ratios (HRs) and 95 % confidence intervals (CIs). During the follow-up with a median of 12.59 years, 701 cases of all-cause death were identified. Among men, the smoothed centile curves of hs-CRP gradually increased from age 35 onwards whereas, the smoothed centile curves of hs-CRP continuously increased as age increased among women. Compared with the reference group, the adjusted HR of the association between elevated hs-CRP and all-cause death was 1.33 (95 % CI: 1.11-1.61). The adjusted HRs of the associations between elevated hs-CRP and all-cause death were higher in women [1.40 (95 % CI: 1.07-1.83)] than men [1.28 (95 % CI: 0.99-1.65) and in subjects aged < 65 years [1.77 (95 % CI: 1.19-2.62)] than in subjects aged ≥ 65 years [1.27 (95 % CI: 1.03-1.57)]. Our findings highlight the need of investigating sex and age differences in biological pathways that link inflammation and mortality.

Efficient and Robust Molecular Solar Thermal Fabric for Personal Thermal Management.

Molecular solar thermal (MOST) materials, which can efficiently capture solar energy and release it as heat on demand, are promising candidates for future personal thermal management (PTM) applications, preferably in the form of fabrics. However, developing MOST fabrics with high energy-storage capacity and stable working performance remains a significant challenge because of the low energy density of the molecular materials and their leakage from the fabric. Here, an efficient and robust MOST fabric for PTM using azopyrazole-containing microcapsules with a deep-UV-filter shell is reported. The MOST fabric, which can co-harvest solar and thermal energy, achieves efficient photocharging and photo-discharging (>90% photoconversion), a high energy density of 2.5 kJ m-2 , and long-term storage sustainability at month scale. Moreover, it can undergo multiple cycles of washing, rubbing, and recharging without significant loss of energy-storage capacity. This MOST microcapsule strategy is easily used for the scalable production of a MOST fabric for solar thermal moxibustion. This achievement offers a promising route for the application of wearable MOST materials with high energy-storage performance and robustness in PTM.

Mechanoluminescent Device: In Situ Renewable Carbazole Derivatives Sandwiched by Self-Healing Disulfide-Containing Polyurethane for Mechanical Signals Detection.

Mechanoluminescent (ML) materials can emit visible light by utilizing mechanical energy, which shows unique advantages in visual mechanical sensing, displays, and biomechanical monitoring due to the correlation between force stimulation and luminescence intensity. Most organic ML materials exhibit luminescence intensity attenuation, disappearing completely with force stimulation and failing to recover. Here, organic luminogens (Cz-alkyl6) can be synthesized by introducing a soft alkyl chain into the carbazole, which exhibits ML emission with self-assembly units. Furthermore, organic luminogens can be generated repeatedly by simply recrystallizing the fracture crystal in situ after a short thermal treatment (70 °C) within 14 s. More importantly, the quantitative correlation between force pressure and ML intensity has been established by a sandwich-type ML device based on a novel carbazole derivative (Cz-alkyl6). The ML device presents a capacity for detecting mechanical signals up to 13 N according to its ML intensity (≤275 a.u.), exhibiting potential application value in engineering damage detection, anticounterfeiting, and advanced visual mechanical sensing.

The relationship between lipid risk score and new-onset hypertension in a prospective cohort study.

Background: Dyslipidemia and hypertension are both important risk factors for atherosclerotic cardiovascular diseases. However, the relationship between dyslipidemia and incident hypertension remains to be elucidated comprehensively. The main purpose of this study was to construct the lipid risk score to explore the risk prediction effect of integrated lipid indices on new-onset hypertension. Methods: This prospective cohort study with 2116 non-hypertensive subjects was conducted from 2009 to 2020. New hypertension events during the follow-up period were recorded and verified. The lipid risk score was calculated by summing coded total cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol weighted with corresponding effect sizes. Cox regression analysis was used to estimate the association between the lipid risk score or lipid indices and incident hypertension in the subgroup of age (< 55 and≥ 55 years at baseline). Results: After a median of 10.75-year follow-up, 637 incident hypertension cases were identified. The restricted cubic spline showed that the lipid risk score had a positive linear correlation with hypertension (P< 0.001). Among people< 55 years, with every increase of 0.94 in lipid risk score, the risk of hypertension increased by 37% (adjusted HR [95%CI]: 1.369 [1.164-1.610]). This association was not modified by overweight or obesity. Conclusions: The integrated lipid risk score, independent of traditional risk factors, has a significantly predictive effect on hypertension in people younger than 55 years. This finding may aid in identifying high-risk individuals for hypertension, as well as facilitating early intervention and management to reduce adverse cardiovascular events. Comprehensive lipid management should be attached importance in the prevention and control of hypertension.

Optically Controlled Thermochromic Switching for Multi-Input Molecular Logic.

Leuco dye-based thermochromic materials offer enormous potential for visible molecular logic due to the appealing reversible color-changing effect. The stable color state is uncontrollable as it depends only on the spontaneous protonation of the leuco dye and color developer. There is still a challenge to propose an effective approach to control bistable color function at required temperature. A family of azobenzenes with various alkyl chains (AZO(n)) is designed for protonation competition with leuco dye. The hydrogen bond and Van der Waals forces are formed between color developer and AZO(n). The color developer can be locked to provide the proton for the leuco dye by Z-AZO(n), while it can be released upon Z-to-E photoisomerization. The locked state can be lasted for more than 16 hours. This optically controlled leuco dye-based system demonstrates a visible sequential logic operation with four-input signals, and provides a new type of protonation-based optical control.

Multifunctional Textile Electronic with Sensing, Energy Storing, and Electrothermal Heating Capabilities.

The development of wearable devices has stimulated significant engineering and technologies of textile electronics (TEs). Improving sensing, energy-storing, and electro-heating capabilities of TEs is still challenging but crucial for their practical applications. Herein, a drip-coating method that constructs a dense ß-FeOOH scaffold on a nylon strip for enhancing polypyrrole loading is proposed, which facilitates the fabrication of highly conductive and hydrophobic PFCNS (polypyrrole/ß-FeOOH/nylon strip). The space provided by the ß-FeOOH scaffold increases the mass of polypyrrole on fibers from 1.1 (polypyrrole/nylon strip) to 3.0 mg cm-2 (polypyrrole/ß-FeOOH/nylon strip), which decreases the resistance from 104.96 to 34.29 Ω cm-1. The PFCNS exhibits a linear elastic modulus of 0.758 MPa within 150% strain, performs a unique resistance variation mechanism, and enables great sensing capability with rapid response time (140 ms), long durability (10,000 stretching-recovering), and effective movement monitoring (e.g., breathing, back bending, jumping). The sensing signals for knee bending have been analyzed in detail by combining with both stretching and pressing response mechanisms. The PFCNS electrode attains a diffusion-controlled capacitance of 574 mF cm-2 and discharging-capacitance of 916 mF cm-2. Furthermore, an interdigitally parallel connection is proposed, which assists the PFCNS heater in achieving high temperature (84 °C) at a low voltage (4 V). This work provides a simple route for nylon-based TEs and promises satisfactory application in wearable sensors, power sources, and heaters.

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.

BACKGROUND: Percutaneous coronary intervention (PCI) is one of the dominant methods for revascularization in patients with coronary heart disease (CHD). However, periprocedural myocardial injury (PMI) is a frequent complication following PCI and is known to be a predictor of postprocedural cardiovascular morbidity and mortality. Although several studies try to identify serum markers to predict the PMI, there is a little information about the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) as a predictor of PMI. Therefore, we aimed to investigate the relationship of Lp-PLA2 levels and PMI in patients undergoing elective PCI. METHODS: This study included 265 consecutive patients with normal preprocedural cardiac troponin T(cTNT) who received elective PCI. The samples for cTNT were collected at 8, 16, and 24 h after PCI to assess perioperative myocardial injury. The Lp-PLA2 and other serum lipid parameters were measured after 12 fasting hours before PCI. RESULTS: The data suggested that the patients with preprocedural high Lp-PLA2 were strongly and independently correlated with the risk of PMI. Pearson correlation analysis showed that preprocedural Lp-PLA2 was significantly positively correlated with postprocedural cTnT elevation (r = 0.694, p < 0.05). Binary logistic regression analysis was used to analyze the risk factors of PMI, we found that Lp-PLA2 was independent risk factor for postprocedural cTnT elevation. The area under Receiver Operating Characteristic curve of Lp-PLA2 was 0.757 (95%CI 0.692 ~ 0.821, p < 0.001), the best cut-off point was 185 ng/ml, sensitivity and specificity were 65.33% and 76.32%. CONCLUSION: Our study demonstrated that preprocedural Lp-PLA2 was associated with postprocedural cTnT elevation and was the independent risk factor of PMI.

Raspberry-Shaped Thermochromic Energy Storage Nanocapsule with Tunable Sunlight Absorption Based on Color Change for Temperature Regulation.

A novel raspberry-shaped thermochromic energy storage nanocapsule (RTESN) is successfully designed and fabricated with switchable sunlight absorption capacity based on color change for temperature regulation. The RTESN is developed by grafting amino-modified silica shell thermochromic nanoparticles (amino-TLD@SiO2 ) on the surface of epoxy-functionalized energy storage nanocapsules (paraffin@PSG), with a total particle size about 450 nm. RTESN exhibits a deep color under low temperatures, which can absorb sunlight for heating. During the continuous thermal energy supply, paraffin@PSG is capable of storing thermal energy owing to its large latent heat capacity of 118.7 J g-1 , thereby maintaining the slow temperature increase. When the temperature is higher than the phase change temperature of paraffin@PSG, the color of amino-TLD@SiO2 turns to white with more reflection of sunlight so that it reduces the absorption of thermal energy and prevents the further increase of temperature. The thermal regulation behavior is confirmed by setting up a wooden house with the surface covered with RTESN. Compared with the blank wooden house, the RTESN covered wooden house (RTESN-H) displays thermal insulation performances during heating and cooling with a maximum temperature difference of 7 °C.

Insight into a Fast-Phototuning Azobenzene Switch for Sustainably Tailoring the Foam Stability.

A photoresponsive surfactant of 4-octoxy-4'-[(trimethylamino)ethoxy]azobenzene (OTAEAzo) has been synthesized for developing a fast-phototuning foam switch based on its high sensitivity, reversibility, and fatigue resistance of the photoisomerization capability. Ultraviolet (UV)-light irradiation for 1 s enabled conversion from the trans isomer to the cis configuration, while exposure to visible (Vis)-light for 3 min induced a cis-to-trans transformation, which maintains an excellent cycling stability for 20 cycles of photoisomerization. The photoisomerization speed depended on the concentration of OTAEAzo, and a lower concentration facilitated a faster photoisomerization process. Because of the low critical micelle concentration (CMC), OTAEAzo with a small dosage of 0.2 g·L-1 showed foamability, which accelerated the photoisomerization speed, enabling it to become a highly efficient switch. The surface activities of trans-OTAEAzo presented distinct differences from those of cis-OTAEAzo, resulting in the foam stabilization effects of trans-OTAEAzo (t1/2 = 2.58 min) and the destabilization effects of cis-OTAEAzo (t1/2 = 0.38 min). Moreover, the foam properties varied slightly in the phototuning cycles. OTAEAzo with low CMC presents high sensitivity and reversible photoisomerization capability, providing an environmental and sustainable approach for tailoring the foam stability.

CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway.

Our previous study proved that CD137-CD137L interaction can regulate the expression of NFATc1. Here, we investigated whether CD137 signaling regulates the expression of NFATc1 in mice VSMCs through TRAF6/NF-κB p65 pathway. Data shows that the CD137 expression can be stimulated by TNF-α in a time-dependent manner in mouse VSMCs. Knockdown of TRAF6 by siTRAF6 significantly attenuated agonist-CD137mAb induced increase of NF-κB p65 and NFATc1 in VSMCs. Pretreatment with a NF-κB inhibitor PDTC for 30 min inhibited the expression of p-p65 in both cytoplasm and nucleus in VSMCs. Thus, the protein level of NFATc1 can be suppressed through inhibition of p-p65. Finally, we also show that the levels of IL-2 and IL-6 can be increased by agonist-CD137 stimulation and decreased when NFATc1 was suppressed. Our data suggest that activated CD137 signaling regulates the expression of NFATc1 and its downstream factors through TRAF6/NF-κB p65 pathways in VSMCs. These findings provide a novel target for treatment of atherosclerosis.

[Nuclear factor-κB pathway mediates the effects of CD137 signaling on NFATc1 expression in mice vascular smooth muscle cells].

OBJECTIVE: To observe whether CD137 signaling could affect the nuclear factor of activated T cells c1 (NFATc1) expression through nuclear factor-κB (NF-κB) pathway in mice aortic vascular smooth muscle cells (VSMCs). METHODS: Adherence methods for tissues explants were used for primary culture of mouse aortic VSMCs. The mRNA expression of CD137 and NFATc1 was detected by real-time quantitative PCR (RT-qPCR). The VSMCs protein expression of IκB-α, NF-κB p65, phospo-p65 and NFATc1 was determined by Western blot. The level of CD137 was measured by Flow Cytometry (FCM). RESULTS: (1) The mRNA and protein expression of CD137 in VSMCs was significantly upregulated at 24 h after co-culture with TNF-α (10 ng/ml, all P < 0.05). (2) Compared with the control group, the level of p-NF-κB p65 in cytoplasm and nucleus was significantly increased (8.34 ± 0.28 vs. 1, P < 0.05, and 2.64 ± 0.42 vs. 1, P < 0.05) while the level of IκB-α was reduced (1 vs. 2.70 ± 0.28, P < 0.05) after co-treatment with agonist-CD137 mAb, above effects were partly blocked by adding specific NF-κB inhibitor PDTC (30 µmol/L: 1.15 ± 0.14 vs. 8.34 ± 0.28, P < 0.05, and 2.09 ± 0.12 vs. 2.64 ± 0.42, P < 0.05, and 1.78 ± 0.74 vs. 1, P < 0.05). (3) The mRNA (2.07 ± 0.09 vs. 1, P < 0.05) and protein (1.75 ± 0.07 vs. 1, P < 0.05) expression of NFATc1 was significantly upregulated by agonist CD137mAb compared with the control group, and these effects could be reversed by PDTC (1.15 ± 0.07 vs. 2.07 ± 0.09, P < 0.05, and 0.90 ± 0.11 vs. 1.75 ± 0.07, P < 0.05). CONCLUSION: CD137 signaling could affect the NFATc1expression in VSMCs through NF-kappaB pathway.

Identification of cis-acting promoter sequences required for expression of the glycerol-3-phosphate acyltransferase 1 gene in mice.

Glycerol-3-phosphate acyltransferase 1 (GPAT1) is a rate limiting enzyme in de novo glycerophospholipid synthesis. The murine GPAT1 promoter sequence (the "classical" sequence) was reported previously. However, the organization of this DNA sequence does not fully match the mouse genome sequences on NCBI/GenBank. Here we have identified net cis-acting promoter sequences for the mouse GPAT1 gene: promoter 1a which includes part of the classical sequence and the downstream promoter 1b. Promoter 1a facilitates transcription of two alternative GPAT1 transcript variants, GPAT1-V1 and V2, while promoter 1b produces a third transcript variant, GPAT1-V3. Upstream stimulating factor-1 (USF-1) controlled both promoters whereas sterol regulatory element-binding protein-1 (SREBP-1) exclusively regulated promoter 1a activity in vitro. Feeding increased GPAT1-V1 and V2, but not V3 mRNA levels in mouse liver. The obese condition of db/db mice did not alter the hepatic expression levels of any of the three GPAT1 variants. Feeding enhanced hepatic mRNA levels, intranuclear protein levels and promoter 1a-binding levels of SREBP-1, but not of USF-1. Thus, promoter 1a was exclusively activated by routine feeding in vivo. Our results indicate differential roles of the two promoters in the regulation of hepatic GPAT1 gene expression in mice.

Alternative splicing produces a constitutively active form of human SREBP-1.

We identified a novel alternative splicing event that constitutively produces a truncated active form of human sterol regulatory element-binding protein 1 (SREBP-1). A cDNA of this splicing variant (named SREBP-1Delta) contains a translational stop codon-encoding exon sequence between exons 7 and 8. It produces SREBP-1aDelta (470 a.a.) and SREBP-1cDelta (446 a.a.) proteins that lack transmembrane and C-terminal regulatory sequences necessary for localization of SREBP-1 to the endoplasmic reticulum. A luciferase reporter assay showed that SREBP-1aDelta and SREBP-1cDelta transactivated lipogenic gene promoters to the same extent as that induced by N-terminal active fragments of SREBP-1a and SREBP-1c, respectively. SREBP-1Delta mRNA is expressed in human cell lines as well as adipose and liver tissues. Expression levels ranged from 5% to 16% of total SREBP-1 expression. The ratio of SREBP-1Delta expression to total SREBP-1 expression in HepG2 cells was not affected by either insulin or high glucose treatment.